- Home
- OZ vs FDMT Comparison
OZ vs FDMT Comparison
Compare OZ & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- FDMT
- Stock Information
- Founded
- OZ 2020
- FDMT 2013
- Country
- OZ United States
- FDMT United States
- Employees
- OZ N/A
- FDMT N/A
- Industry
- OZ
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- OZ
- FDMT Health Care
- Exchange
- OZ Nasdaq
- FDMT Nasdaq
- Market Cap
- OZ 239.8M
- FDMT 192.2M
- IPO Year
- OZ N/A
- FDMT 2020
- Fundamental
- Price
- OZ $64.75
- FDMT $4.08
- Analyst Decision
- OZ
- FDMT Buy
- Analyst Count
- OZ 0
- FDMT 10
- Target Price
- OZ N/A
- FDMT $32.33
- AVG Volume (30 Days)
- OZ 1.8K
- FDMT 461.8K
- Earning Date
- OZ 01-01-0001
- FDMT 08-07-2025
- Dividend Yield
- OZ N/A
- FDMT N/A
- EPS Growth
- OZ N/A
- FDMT N/A
- EPS
- OZ N/A
- FDMT N/A
- Revenue
- OZ $4,077,000.00
- FDMT $23,000.00
- Revenue This Year
- OZ N/A
- FDMT $13,048.65
- Revenue Next Year
- OZ N/A
- FDMT N/A
- P/E Ratio
- OZ N/A
- FDMT N/A
- Revenue Growth
- OZ 94.70
- FDMT N/A
- 52 Week Low
- OZ $56.77
- FDMT $2.24
- 52 Week High
- OZ $82.89
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- OZ 47.95
- FDMT 52.91
- Support Level
- OZ $64.64
- FDMT $3.73
- Resistance Level
- OZ $66.01
- FDMT $4.62
- Average True Range (ATR)
- OZ 0.77
- FDMT 0.33
- MACD
- OZ -0.22
- FDMT -0.06
- Stochastic Oscillator
- OZ 18.75
- FDMT 25.55
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.